Press Release
Candel Therapeutics (NASDAQ: CADL) Reports Positive Data From Phase 2 Trial Of CAN-2409 In Borderline Resectable Pancreatic Cancer
–News Direct–
By Jeremy Golden, Benzinga
Clinical-stage biopharmaceutical company Candel Therapeutics, Inc. (NASDAQ: CADL) reported updated survival data from its randomized phase 2 clinical trial of CAN-2409 in borderline resectable pancreatic cancer. Pancreatic cancer is the fourth leading cause of cancer-related death in the U.S. The disease accounts for approximately 3% of all cancers, with an estimated 64,050 patients diagnosed in 2023.
The randomized, controlled clinical trial is specifically looking into the safety and efficacy of CAN-2409 plus valacyclovir (prodrug), together with standard of care (SoC) chemoradiation, followed by resection if possible in borderline resectable pancreatic ductal adenocarcinoma (PDAC).
Very encouraging results were recently reported by the Needham, Massachusetts-based company.
Patients reached an estimated median overall survival of 28.8 months after experimental treatment with CAN-2409 versus only 12.5 months in the control group in PDAC. At 24 months, the survival rate was 71.4% in CAN-2409 treated patients compared to only 16.7% in the control group after chemoradiation. Thus, prolonged and sustained survival was observed after experimental treatment with CAN-2409 in patients with borderline resectable PDAC. Importantly, 4 out of 7 patients who received CAN-2409 were still alive at the time of data cut-off, with 2 patients surviving more than 50.0 months from enrollment. Only 1 out of 6 patients in the randomized control SoC chemotherapy group remained alive at the data cut-off (50.6 months).
No new safety signals were observed, providing further support that multiple injections of CAN-2409 are generally well tolerated. Additionally, there were no dose-limiting toxicities or cases of pancreatitis reported.
Previous analysis of resected tumors showed dense aggregates of immune cells including CD8+, cytotoxic tumor-infiltrating lymphocytes and dendritic cells in PDAC tissue after CAN-2409 administration. This reinforces the potential of CAN-2409 to activate a robust antitumoral immune response in patients with cancer also in cold, immunosuppressive tumors like PDAC.
Given the frequent recurrence and short survival with SoC chemotherapy for non-metastatic PDAC, effective new treatment options are urgently needed, said Garrett Nichols, MD, MS, Chief Medical Officer of Candel. We are very encouraged by the improved survival associated with CAN-2409, which has been shown to be durable after prolonged follow-up based on the updated data in this randomized clinical trial. CAN-2409 was generally well tolerated without significant additional local or systemic toxicity when added to SoC chemoradiation.
Candels most advanced viral immunotherapy candidate, CAN-2409, is an investigational off-the-shelf, replication-defective adenovirus designed to induce an individualized, systemic immune response against the tumor. Because of its versatility, CAN-2409 has the potential to treat a broad range of solid tumors. More than 1,000 patients have been dosed with CAN-2409 to date, with a favorable reported tolerability profile and proof of concept in each indication that the company is currently pursuing.
CAN-2409 is injected directly into the tumor or target tissue using a localized injection method that is akin to the standard approach for in situ vaccination to elicit an immune response against the injected tumor and uninjected metastases.
Long-term survival data in PDAC was recently updated with eight months of further follow-up since the first analysis was presented at the 2023 Society for Immunotherapy (SITC) Annual Meeting. Based on the data presented at SITC, the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to Candel Therapeutics for CAN-2409 in combination with valacyclovir for the treatment of patients with PDAC in December 2023. More recently, the FDA also granted Orphan Drug Designation.
The failure of conventional immunotherapy to improve outcomes in pancreatic cancer is attributed to the highly immunosuppressive tumor microenvironment, which is largely devoid of immune cells, said Paul Peter Tak, MD, PhD, FMedSci, President and Chief Executive Officer of Candel. The immunological changes induced by CAN-2409, evident in the pancreatic tissue and the peripheral blood after administration, suggest that CAN-2409 is able to change the balance between the tumor and the patients anti-tumor immune response, which can convert progressive cancer into a chronic disease associated with improved survival.
Featured photo by National Cancer Institute on Unsplash.
Candel is a clinical stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. Candel has established two clinical stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform and is currently in ongoing clinical trials in non-small cell lung cancer (NSCLC) (phase 2), borderline resectable pancreatic cancer (phase 2), and localized, non-metastatic prostate cancer (phase 2 and phase 3). CAN-3110 is the lead product candidate from the HSV platform and is currently in an ongoing investigator-sponsored phase 1 clinical trial in recurrent high-grade glioma (HGG). Finally, Candels enLIGHTEN Discovery Platform is a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors.
This article includes certain disclosures that contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, express or implied statements regarding the timing and advancement of development programs, including the timing and availability of additional data, key data readout milestones, including CAN-3110 in HGG; expectations regarding the potential benefits conferred by Fast Track Designation; expectations regarding the therapeutic benefit of its programs, including the potential for its programs to extend patient survival; and expectations regarding cash runway and expenditures. The words may, will, could, would, should, expect, plan, anticipate, intend, believe, estimate, predict, project, potential, continue, target and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release are based on managements current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, those risks and uncertainties related to the timing and advancement of development programs; expectations regarding the therapeutic benefit of the Companys programs; that final data from our pre-clinical studies and completed clinical trials may differ materially from reported interim data from ongoing studies and trials; the Companys ability to efficiently discover and develop product candidates; the Companys ability to obtain and maintain regulatory approval of product candidates; the Companys ability to maintain its intellectual property; the implementation of the Companys business model, and strategic plans for the Companys business and product candidates, and other risks identified in the Companys SEC filings, including the Companys most recent Quarterly Report on Form 10-Q filed with the SEC, and subsequent filings with the SEC. The Company cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. The Company disclaims any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements. Any forward-looking statements contained in this press release represent the Companys views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date.
This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.
Contact Details
Aljanae Reynolds
+1 617-916-5445
Company Website
View source version on newsdirect.com: https://newsdirect.com/news/candel-therapeutics-nasdaq-cadl-reports-positive-data-from-phase-2-trial-of-can-2409-in-borderline-resectable-pancreatic-cancer-425692953
Candel Therapeutics
COMTEX_453283087/2655/2024-06-03T08:31:08
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
PU Prime is excited to introduce its VPS Promotion, designed to help traders achieve seamless, uninterrupted trading. By meeting the deposit and trading volume requirements, eligible clients can get their VPS costs refunded, ensuring a stable and high-speed trading environment.
Why Use a VPS?
A Virtual Private Server (VPS) allows traders to execute their strategies with ultra-low latency, enhanced stability, and top-tier security. Whether you’re running Expert Advisors (EAs), automated trading systems, or manual trades, a VPS ensures your orders are executed efficiently, without interruptions.
Key Benefits of Using a VPS for Trading
Always-On Trading – Keep your trades running 24/7, even when your device is off.
Ultra-Low Latency – Minimize slippage and execute trades faster with optimized server performance.
Stable & Secure – Benefit from 99.9% uptime, dedicated bandwidth, and advanced security features.
Access Anywhere – Trade from any device, anywhere, with a seamless connection.
By leveraging a VPS, traders gain a crucial advantage in maintaining consistent performance, particularly during high volatility market conditions, ensuring trades are executed with precision and reliability.
How to Get Your Free VPS
Follow these simple steps to claim your VPS refund and experience uninterrupted trading:
For New and Existing Clients
- Deposit – Open a live trading account with PU Prime and deposit at least $1,000 USD to qualify.
- Choose a VPS Provider – Select and activate a VPS service of your choice based on your trading needs.
- Meet the Trading Requirement – Trade a minimum monthly notional value of:
- $0.5 million on closed trades to receive a $25 USD refund
- $1 million on closed trades to receive a $50 USD refund
- Submit Your Refund Request – Upload your VPS invoice via the PU Prime Client Portal, and we’ll credit your refund directly into your trading account.
Note: Limited to one VPS refund per client per month. Terms and conditions apply.
Unlock the Full Potential of Your Trades
At PU Prime, we are committed to providing traders with the best tools and trading conditions. Our VPS promotion ensures you stay connected, execute trades without disruptions, and enhance your overall trading performance.
For more details, visit the PU Prime Promotions Page or contact our support team.
For media inquiries, please contact the PU Prime PR team via media@puprime.com.
About PU Prime
Founded in 2015, PU Prime is a leading global fintech company providing innovative online trading solutions. Today, we offer regulated financial products across various asset classes, including forex, commodities, indices, and shares. Committed to providing advanced technology and educational resources, PU Prime supports traders and investors at every stage, from beginner to professional. With a presence in over 200 countries and exceeding 40 million app downloads, PU Prime is dedicated to enabling financial success and fostering a global community of empowered traders. Discover PU Prime’s latest promotions and join us for a fruitful trading journey today.
Company Information
Organization:PU Prime
Contact Person Name:Qianyi Hong
Website:https://www.puprime.com/
Email:media@puprime.com
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
PU Prime, a globally acclaimed online trading platform, has secured the coveted title of Best Partnership Program Brokerage Firm Global 2025, awarded by the prestigious Global Business & Finance Magazine. This recognition shines a spotlight on PU Prime’s unwavering dedication to excellence, groundbreaking innovation, and top-tier partnership offerings that set it apart in the financial world.
The Global Business & Finance Magazine stands as a trusted authority, delivering sharp, unbiased insights into the international business and finance scene. With a team of veteran journalists and industry experts, the magazine keeps its audience ahead of the curve on global markets, investment tactics, corporate finance, and economic policies. Through its renowned awards, it celebrates trailblazers—individuals, companies, and organizations—that push the boundaries of achievement in the business and finance sectors.
A Nod to PU Prime’s Stellar Standards
The Best Partnership Program Brokerage Firm Global award highlights firms excelling in service, transparency, and partner value. PU Prime’s partnership program has been a game-changer, building strong, win-win relationships with affiliates, introducing brokers (IBs), and institutional partners across the globe. Armed with cutting-edge trading tech, lucrative commission setups, and hands-on support, PU Prime is redefining what’s possible in financial services.
This global accolade cements PU Prime’s status as a frontrunner in the financial markets, driven by its relentless push to refine its partnership model with fresh strategies, sharper tools, and flawless user experiences.
Fueling Progress and Breaking New Ground
PU Prime’s award-winning program packs a punch with perks like:
- Lucrative, clear-cut commission plans
- Next-level trading platforms and tech
- Tailored account management and support
- Robust marketing and branding resources
- Broad access to trading instruments and liquidity
By pouring resources into its partners and delivering elite tools, PU Prime locks in growth and success amid a fast-changing financial landscape.
Eyes on the Future
As PU Prime basks in this milestone, the firm is already gearing up to broaden its global footprint and supercharge its partnership network. Built on trust, dependability, and bold innovation, PU Prime is poised to keep empowering partners and traders while raising the bar for the industry.
For press inquiries, reach out to our PR crew at media@puprime.com.
About PU Prime
Founded in 2015, PU Prime is a leading global fintech company providing innovative online trading solutions. Today, we offer regulated financial products across various asset classes, including forex, commodities, indices, and shares. Committed to providing advanced technology and educational resources, PU Prime supports traders and investors at every stage, from beginner to professional. With a presence in over 200 countries and exceeding 40 million app downloads, PU Prime is dedicated to enabling financial success and fostering a global community of empowered traders. Discover PU Prime’s latest promotions and join us for a fruitful trading journey today.
Company Information
Organization:PU Prime
Contact Person Name:Qianyi Hong
Website:https://www.puprime.com/
Email:media@puprime.com
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
PU Prime, a globally recognized online trading platform, is proud to announce its partnership with the Argentine Football Association (AFA) as an Official Regional Sponsor. The partnership, commencing on March 17, 2025, underscores PU Prime’s commitment to excellence and innovation, aligning with one of the most iconic institutions in world football.
This collaboration reflects the shared values between football and trading—discipline, strategy, and execution—all of which are key to achieving success both on and off the field. PU Prime will leverage this partnership to strengthen its regional presence while engaging with football fans through exclusive experiences and unique promotional activities.
As part of the agreement, PU Prime will gain access to a wide range of marketing assets, including exclusive VIP experiences, match tickets, and signed jerseys from AFA icons. These exclusive opportunities will enhance PU Prime’s brand presence and engagement within the football community.
“We are delighted to welcome PU Prime as an official sponsor of the Argentine Football Association. At AFA, we continue to collaborate with strategic partners that share our vision and values, both on and off the pitch. PU Prime’s leadership in its sector aligns with our commitment to excellence, and we look forward to a strong and successful partnership,” said Claudio Fabián Tapia, President of AFA.
“We are honored to partner with such a legendary institution. Just as the Argentina National Team has cemented its place as a powerhouse in world football, PU Prime is on a similar trajectory—continuously evolving, innovating, and striving for excellence. This collaboration embodies the spirit of teamwork and perseverance, values that define both great football teams and great trading platforms,” added Daniel Bruce, Managing Director of PU Prime.
More than just a sponsorship, this partnership is a tribute to passion, performance, and the relentless pursuit of excellence. Whether in trading or football, success is driven by precision, strategy, and commitment. PU Prime is excited to bring exclusive experiences to its clients, reinforcing its dedication to innovation and excellence in every aspect of its business.
For more information about the partnership, please visit https://www.puprime.com/pu-prime-becomes-the-official-regional-sponsor-of-the-argentine-football-association/ .
About AFA
Founded in 1893, the Argentine Football Association (AFA) is the governing body of football in Argentina and one of the oldest football federations in the world. Headquartered in Buenos Aires, AFA oversees all aspects of the sport, including the organization of domestic leagues such as the Primera División, Primera Nacional, and lower divisions, as well as national cup competitions like the Copa Argentina and Supercopa Argentina.
For more information, kindly refer to afa.com.ar.
Company Information
Organization:PU Prime
Contact Person Name:Qianyi Hong
Website:https://www.puprime.com/
Email:media@puprime.com
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
PU Prime Launches Evergreen VPS Promotion to Elevate Trading Performance
PU Prime Clinches Top Honor as Best Partnership Program Brokerage Firm Global 2025
PU Prime Becomes the Official Regional Sponsor of the Argentine Football Association
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Apu Apustaja Conquers New York with Lively Street Ads, Including Times Square Billboard
-
Press Release6 days ago
Crescent Petroleum and Dana Gas reach 500 MMboe cumulative production from Khor Mor field, announce major growth and development plans
-
Press Release6 days ago
Dr. Akira Olsen Releases New Book Focused on Personal Growth and Mental Wellness for Gen Z and Millennials
-
Press Release7 days ago
Founded by Kenyan-American Josephine K. Stegeman, Human Rights Vision Group Unveils Expanded Global Empowerment & Social Progress Services
-
Press Release6 days ago
Dr. Akira Olsen Releases New Book Focused on Personal Growth and Mental Wellness for Gen Z and Millennials
-
Press Release6 days ago
ForexRova Debuts at International Forex Conference, Promises Smarter Gold Trading Solutions
-
Press Release5 days ago
1847 Holdings Delisted: Not a Failed Business—A Publicly Traded Ponzi Scheme
-
Press Release6 days ago
10 Reasons Why We Should Exercise Our Dogs Daily
-
Press Release7 days ago
Mad Railz: The Multi-Talented Force Taking Over Music